- Home
- FBNC vs CNMD Comparison
FBNC vs CNMD Comparison
Compare FBNC & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBNC
- CNMD
- Stock Information
- Founded
- FBNC 1934
- CNMD 1970
- Country
- FBNC United States
- CNMD United States
- Employees
- FBNC N/A
- CNMD N/A
- Industry
- FBNC Major Banks
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FBNC Finance
- CNMD Health Care
- Exchange
- FBNC Nasdaq
- CNMD Nasdaq
- Market Cap
- FBNC 1.7B
- CNMD 1.7B
- IPO Year
- FBNC N/A
- CNMD 1987
- Fundamental
- Price
- FBNC $37.12
- CNMD $48.59
- Analyst Decision
- FBNC Buy
- CNMD Buy
- Analyst Count
- FBNC 3
- CNMD 5
- Target Price
- FBNC $52.00
- CNMD $77.20
- AVG Volume (30 Days)
- FBNC 213.3K
- CNMD 536.8K
- Earning Date
- FBNC 04-28-2025
- CNMD 04-30-2025
- Dividend Yield
- FBNC 2.37%
- CNMD 1.65%
- EPS Growth
- FBNC N/A
- CNMD 108.33
- EPS
- FBNC 1.84
- CNMD 4.25
- Revenue
- FBNC $333,724,000.00
- CNMD $1,307,015,000.00
- Revenue This Year
- FBNC $32.91
- CNMD $5.97
- Revenue Next Year
- FBNC $6.21
- CNMD $5.63
- P/E Ratio
- FBNC $20.13
- CNMD $11.43
- Revenue Growth
- FBNC N/A
- CNMD 5.00
- 52 Week Low
- FBNC $29.53
- CNMD $47.25
- 52 Week High
- FBNC $50.34
- CNMD $78.58
- Technical
- Relative Strength Index (RSI)
- FBNC 41.02
- CNMD 32.11
- Support Level
- FBNC $36.38
- CNMD $47.25
- Resistance Level
- FBNC $37.36
- CNMD $57.17
- Average True Range (ATR)
- FBNC 1.86
- CNMD 3.25
- MACD
- FBNC -0.04
- CNMD -0.81
- Stochastic Oscillator
- FBNC 41.59
- CNMD 9.65
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.